{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-023155","form_type":"8-K","ticker":"INBS","cik":"0001725430","company_name":"INTELLIGENT BIO SOLUTIONS INC.","filed_at":"2024-06-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.758745+00:00","generated_at":"2026-06-01T05:37:45.988502+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Director Christopher Towers resigns; Nicola Fraser appointed to board and Audit Committee Chair","bullets":["Christopher Towers resigned from Board and all committees effective June 7, 2024; not due to any disagreement.","Nicola Fraser appointed to Board to fill vacancy; appointed as Chair of Audit Committee.","Fraser is Managing Partner of NextKey Services LLC and former Executive Director at JP Morgan Chase.","Steven Boyages appointed to Compensation and Nominating Committees; becomes Chair of Nominating and Corporate Governance Committee."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-023155","json":"https://secwatch.observer/filing/0001493152-24-023155.json","markdown":"https://secwatch.observer/filing/0001493152-24-023155.md","text":"https://secwatch.observer/filing/0001493152-24-023155.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725430/000149315224023155/0001493152-24-023155-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725430/000149315224023155/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:37:45.988502+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"70661c6812","claim":"Nicola Fraser was appointed as Director at INTELLIGENT BIO SOLUTIONS INC..","evidence_excerpt":"On June 7, 2024, upon recommendation of the Nominating and Corporate Governance Committee, the Board appointed Nicola Fraser to the Board to fill the vacancy created by Mr. Tower’s resignation.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1725430/000149315224023155/0001493152-24-023155-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"fafce72fec","claim":"Christopher Towers resigned as Director at INTELLIGENT BIO SOLUTIONS INC..","evidence_excerpt":"On June 6, 2024, Christopher Towers resigned from the Board of Directors (the “Board”) of Intelligent Bio Solutions Inc. (the “Company”), effective June 7, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1725430/000149315224023155/0001493152-24-023155-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}